vs

Side-by-side financial comparison of biote Corp. (BTMD) and Red Violet, Inc. (RDVT). Click either name above to swap in a different company.

biote Corp. is the larger business by last-quarter revenue ($46.4M vs $23.4M, roughly 2.0× Red Violet, Inc.). Red Violet, Inc. runs the higher net margin — 12.0% vs 4.2%, a 7.8% gap on every dollar of revenue. On growth, Red Violet, Inc. posted the faster year-over-year revenue change (19.6% vs -6.9%). Red Violet, Inc. produced more free cash flow last quarter ($6.6M vs $6.5M). Over the past eight quarters, Red Violet, Inc.'s revenue compounded faster (15.6% CAGR vs -0.4%).

biote Corp is a healthcare company specializing in personalized bioidentical hormone replacement therapy solutions for adult men and women. It operates primarily in the U.S. market, offering training programs for licensed healthcare providers, along with complementary wellness supplements and diagnostic services to support patient care outcomes.

Red Violet, Inc. is a technology firm specializing in advanced data analytics, risk mitigation, and identity verification solutions. It serves clients across law enforcement, financial services, insurance, and corporate compliance sectors, delivering actionable insights from curated public and proprietary data sets to support informed decision-making.

BTMD vs RDVT — Head-to-Head

Bigger by revenue
BTMD
BTMD
2.0× larger
BTMD
$46.4M
$23.4M
RDVT
Growing faster (revenue YoY)
RDVT
RDVT
+26.4% gap
RDVT
19.6%
-6.9%
BTMD
Higher net margin
RDVT
RDVT
7.8% more per $
RDVT
12.0%
4.2%
BTMD
More free cash flow
RDVT
RDVT
$73.0K more FCF
RDVT
$6.6M
$6.5M
BTMD
Faster 2-yr revenue CAGR
RDVT
RDVT
Annualised
RDVT
15.6%
-0.4%
BTMD

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
BTMD
BTMD
RDVT
RDVT
Revenue
$46.4M
$23.4M
Net Profit
$2.0M
$2.8M
Gross Margin
Operating Margin
14.7%
6.8%
Net Margin
4.2%
12.0%
Revenue YoY
-6.9%
19.6%
Net Profit YoY
-47.2%
226.2%
EPS (diluted)
$0.05
$0.20

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BTMD
BTMD
RDVT
RDVT
Q4 25
$46.4M
$23.4M
Q3 25
$48.0M
$23.1M
Q2 25
$48.9M
$21.8M
Q1 25
$49.0M
$22.0M
Q4 24
$49.8M
$19.6M
Q3 24
$51.4M
$19.1M
Q2 24
$49.2M
$19.1M
Q1 24
$46.8M
$17.5M
Net Profit
BTMD
BTMD
RDVT
RDVT
Q4 25
$2.0M
$2.8M
Q3 25
$8.2M
$4.2M
Q2 25
$3.2M
$2.7M
Q1 25
$13.7M
$3.4M
Q4 24
$3.7M
$863.0K
Q3 24
$10.7M
$1.7M
Q2 24
$-7.1M
$2.6M
Q1 24
$-4.2M
$1.8M
Operating Margin
BTMD
BTMD
RDVT
RDVT
Q4 25
14.7%
6.8%
Q3 25
17.2%
19.8%
Q2 25
22.0%
12.6%
Q1 25
19.8%
19.1%
Q4 24
5.6%
1.9%
Q3 24
23.7%
13.1%
Q2 24
12.7%
16.1%
Q1 24
22.3%
11.3%
Net Margin
BTMD
BTMD
RDVT
RDVT
Q4 25
4.2%
12.0%
Q3 25
17.1%
18.3%
Q2 25
6.5%
12.3%
Q1 25
28.0%
15.6%
Q4 24
7.4%
4.4%
Q3 24
20.8%
9.0%
Q2 24
-14.4%
13.8%
Q1 24
-8.9%
10.2%
EPS (diluted)
BTMD
BTMD
RDVT
RDVT
Q4 25
$0.05
$0.20
Q3 25
$0.22
$0.29
Q2 25
$0.10
$0.18
Q1 25
$0.37
$0.24
Q4 24
$0.09
$0.06
Q3 24
$0.33
$0.12
Q2 24
$-0.21
$0.19
Q1 24
$-0.12
$0.13

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BTMD
BTMD
RDVT
RDVT
Cash + ST InvestmentsLiquidity on hand
$24.1M
$43.6M
Total DebtLower is stronger
$103.1M
Stockholders' EquityBook value
$-58.5M
$100.9M
Total Assets
$107.6M
$112.0M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BTMD
BTMD
RDVT
RDVT
Q4 25
$24.1M
$43.6M
Q3 25
$28.0M
$45.4M
Q2 25
$19.6M
$38.8M
Q1 25
$41.7M
$34.6M
Q4 24
$39.3M
$36.5M
Q3 24
$38.2M
$35.7M
Q2 24
$26.4M
$30.9M
Q1 24
$78.8M
$32.1M
Total Debt
BTMD
BTMD
RDVT
RDVT
Q4 25
$103.1M
Q3 25
$104.7M
Q2 25
$106.3M
Q1 25
$107.8M
Q4 24
$109.4M
Q3 24
$110.9M
Q2 24
$112.5M
Q1 24
$114.1M
Stockholders' Equity
BTMD
BTMD
RDVT
RDVT
Q4 25
$-58.5M
$100.9M
Q3 25
$-72.8M
$101.7M
Q2 25
$-85.1M
$96.2M
Q1 25
$-90.0M
$91.8M
Q4 24
$-105.9M
$86.6M
Q3 24
$-130.3M
$91.7M
Q2 24
$-143.2M
$88.0M
Q1 24
$-36.0M
$83.8M
Total Assets
BTMD
BTMD
RDVT
RDVT
Q4 25
$107.6M
$112.0M
Q3 25
$111.3M
$112.1M
Q2 25
$104.8M
$104.8M
Q1 25
$123.4M
$99.1M
Q4 24
$122.4M
$98.5M
Q3 24
$101.3M
$98.0M
Q2 24
$92.9M
$93.5M
Q1 24
$160.1M
$94.0M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BTMD
BTMD
RDVT
RDVT
Operating Cash FlowLast quarter
$7.6M
$6.7M
Free Cash FlowOCF − Capex
$6.5M
$6.6M
FCF MarginFCF / Revenue
14.0%
28.1%
Capex IntensityCapex / Revenue
2.3%
0.5%
Cash ConversionOCF / Net Profit
3.87×
2.38×
TTM Free Cash FlowTrailing 4 quarters
$30.2M
$28.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BTMD
BTMD
RDVT
RDVT
Q4 25
$7.6M
$6.7M
Q3 25
$14.1M
$10.2M
Q2 25
$7.1M
$7.5M
Q1 25
$6.5M
$5.0M
Q4 24
$12.4M
$6.7M
Q3 24
$15.6M
$7.2M
Q2 24
$9.9M
$5.7M
Q1 24
$7.4M
$4.3M
Free Cash Flow
BTMD
BTMD
RDVT
RDVT
Q4 25
$6.5M
$6.6M
Q3 25
$13.6M
$10.0M
Q2 25
$5.3M
$7.3M
Q1 25
$4.8M
$5.0M
Q4 24
$10.7M
$6.7M
Q3 24
$14.0M
$7.2M
Q2 24
$7.4M
$5.7M
Q1 24
$6.7M
$4.2M
FCF Margin
BTMD
BTMD
RDVT
RDVT
Q4 25
14.0%
28.1%
Q3 25
28.3%
43.3%
Q2 25
10.8%
33.5%
Q1 25
9.9%
22.5%
Q4 24
21.5%
34.1%
Q3 24
27.3%
37.8%
Q2 24
15.1%
29.7%
Q1 24
14.2%
24.2%
Capex Intensity
BTMD
BTMD
RDVT
RDVT
Q4 25
2.3%
0.5%
Q3 25
1.0%
0.8%
Q2 25
3.7%
0.9%
Q1 25
3.3%
0.2%
Q4 24
3.4%
0.1%
Q3 24
3.0%
0.2%
Q2 24
5.1%
0.3%
Q1 24
1.5%
0.4%
Cash Conversion
BTMD
BTMD
RDVT
RDVT
Q4 25
3.87×
2.38×
Q3 25
1.72×
2.41×
Q2 25
2.22×
2.79×
Q1 25
0.47×
1.45×
Q4 24
3.34×
7.75×
Q3 24
1.45×
4.22×
Q2 24
2.17×
Q1 24
2.41×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BTMD
BTMD

Product Revenue$45.3M98%
Disposable Trocars Product Revenue$1.2M3%

RDVT
RDVT

Segment breakdown not available.

Related Comparisons